-
Alonso committed to Aston Martin, but keeping options open
-
Hospitals raise alert as heatwave slams Europe
-
Events cancelled, records loom as heatwave reaches Germany
-
'Alligator Alcatraz' detention center shuts in US: official
-
Czech striker Schick ends international career
-
Tennis great Evert says 'relentless' cancer has returned
-
US says wants deal with Iran, but not 'at any price'
-
Colombian president-elect gives armed groups one month to surrender
-
US Supreme Court hands win to Bayer in weedkiller litigation
-
New Zealand's Latham and Conway pile on the runs before Stokes breakthrough
-
Apple raises prices for MacBooks and iPads, as costs soar over AI
-
Dominant Osaka sails into Bad Homburg semis
-
UK suffers as heat breaks new June record
-
US Supreme Court says asylum seekers can be turned away before border
-
Binance to suspend crypto services in several EU countries
-
Olivia Wilde looks at evolving relationships in 'The Invite'
-
Hamilton reveals neck injury that hampered debut year with Ferrari
-
Rows, drones and 'sorry' Son as South Korea await World Cup fate
-
Noosha Aubel and Dietmar Woidke: How Potsdam Is Letting Down a Young Child with Profound Disabilities
-
Antonelli welcomes Mercedes upgrade as Russell says beware Hamilton
-
Greek families receive keepsakes of Holocaust victims
-
Antonelli welcomes Mercedes upgrade ast Russell says beware Hamilton
-
Easyjet rejects latest takeover bid but leaves door ajar
-
HRW denounces Turkey arrests ahead of NATO summit
-
Macron hosts Meloni for Riviera talks after Trump rift
-
Alonso committed to Aston Martin, but is keeping options open
-
US Supreme Court paves way for mass deportation of Haitians, Syrians
-
Venezuelans trapped alive after twin quakes kill at least 164
-
South Africa vows firm response to anti-migrant violence
-
New Zealand make England toil as Stokes returns for series decider
-
Poland, Ukraine hold key Gdansk conference without Zelensky
-
Americans impacted by climate change demand answers from lawmakers
-
Massive police deployment blocks Kenya protest anniversary
-
Heat-struck Italians cool off in ancient stone 'trulli'
-
Court orders TotalEnergies to account for clients' emissions
-
French teaching unions call strike over 'unacceptable' heat
-
Stocks rally on renewed AI optimism, oil price declines
-
US Fed's preferred inflation gauge hits fresh three-year high
-
Venezuela twin quakes kill at least 164 with many trapped under rubble
-
Dominant Osaka cruises into Bad Homburg semis
-
IOC votes to continue ski mountaineering for 2030 Games
-
New Zealand frustrate England as Stokes returns for series decider
-
Stocks rally on AI optimism after Micron's blowout forecast
-
Poland, Ukraine tone down dispute at reconstruction conference
-
Tunisia's short-lived World Cup experience lays bare deep dysfunctions
-
At-risk UK elderly bid to stay cool as heatwave bears down
-
'Everything collapsed': Venezuela region hit hardest by quakes cries for help
-
'Need each other': Macron hosts Meloni after Trump rift
-
Kenya police turn out in force on protest anniversary
-
Stokes straight back into the action as New Zealand bat in 3rd Test
Moderna to Present at Upcoming Conferences in March 2026
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
TD Cowen 46th Annual Healthcare Conference, on Tuesday, March 3rd at 1:50pm ET
Barclays 28th Annual Global Healthcare Conference, on Tuesday, March 10th at 9:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
H.Thompson--AT